obg_manag_jan_19_210.png Applying Guidelines in Practice: Noninvasive Prenatal Testing 1.0 AMA PRA Category 1 Credits™ obg_manag_jan_19_210.png Evolving Strategies in the Diagnosis and Management of Hemolytic Disease of the Fetus and Newborn 0.25 AMA PRA Category 1 Credits™ obg_manag_jan_19_210.png Expanding Contraceptive Choices for Women: The Vaginal pH Modulator 0.25 AMA PRA Category 1 Credits™ obg_manag_jan_19_210.png The Clinical Conundrum in Managing Preterm Birth: Balancing Historical Trial Results, Society Guidelines, and Clinical Experience with a Contradictory Trial Outcome 0.25 AMA PRA Category 1 Credits™ obg_manag_jan_19_210.png Ospemifene, an oral SERM for dyspareunia of menopause: Is it being underutilized? 1.0 AMA PRA Category 1 Credit(s)™ meeting_challenge_cme.png Meeting the Challenge of Atopic Dermatitis From Infancy to Adulthood Expired new_treatment_suppl_thumb_210_110.png New Treatment Paradigms in Psoriasis: Understanding and Incorporating Recent and Emerging Trends Expired obg_manag_210.png Endometrial Evaluation: Are You Still Relying on a Blind Biopsy? Expired SCMSOnychomycosis_Supplement_cover_new.png Managing Onychomycosis: New and Emerging Treatments and Recurrence Prevention Strategies Expired obg_manag_april_19_210.png Counseling Your Patients About Hypoactive Sexual Desire Disorder and Advances in its Diagnosis and Treatment Expired obg_manag_04_18_210.png Dyspareunia Associated with Vulvovaginal Atrophy: Innovations in Counseling, Diagnosis, and Management Expired
obg_manag_jan_19_210.png Applying Guidelines in Practice: Noninvasive Prenatal Testing 1.0 AMA PRA Category 1 Credits™
obg_manag_jan_19_210.png Evolving Strategies in the Diagnosis and Management of Hemolytic Disease of the Fetus and Newborn 0.25 AMA PRA Category 1 Credits™
obg_manag_jan_19_210.png Expanding Contraceptive Choices for Women: The Vaginal pH Modulator 0.25 AMA PRA Category 1 Credits™
obg_manag_jan_19_210.png The Clinical Conundrum in Managing Preterm Birth: Balancing Historical Trial Results, Society Guidelines, and Clinical Experience with a Contradictory Trial Outcome 0.25 AMA PRA Category 1 Credits™
obg_manag_jan_19_210.png Ospemifene, an oral SERM for dyspareunia of menopause: Is it being underutilized? 1.0 AMA PRA Category 1 Credit(s)™
meeting_challenge_cme.png Meeting the Challenge of Atopic Dermatitis From Infancy to Adulthood Expired
new_treatment_suppl_thumb_210_110.png New Treatment Paradigms in Psoriasis: Understanding and Incorporating Recent and Emerging Trends Expired
SCMSOnychomycosis_Supplement_cover_new.png Managing Onychomycosis: New and Emerging Treatments and Recurrence Prevention Strategies Expired
obg_manag_april_19_210.png Counseling Your Patients About Hypoactive Sexual Desire Disorder and Advances in its Diagnosis and Treatment Expired
obg_manag_04_18_210.png Dyspareunia Associated with Vulvovaginal Atrophy: Innovations in Counseling, Diagnosis, and Management Expired
